Biologics Market Size, Share Global Analysis Report, 2019–2026

report img

Biologics Market By Type Analysis (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Antisense, RNAi, & Molecular Therapy, and Others), by Source Analysis (Microbial, Mammalian, and Others), by Disease Category (Oncology, Infectious Diseases, Immunological Disorders, Cardiovascular Disorders, Hematological Disorders, and Others), by Manufacturing (In-house and Outsourced), and by Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa): Global Industry Perspective, Market Size, Statistical Research, Market Intelligence, Comprehensive Analysis, Historical Trends, and Forecast 2019–2026

Industry Insights

This professional and specialized report study examines the technical and business perspective of the biologics industry. The report provides a historical analysis of the industry as well as the projected trends expected to be witnessed in the biologics market. The report study analyzes the market statistics at the global as well as the regional levels to gain an in-depth perspective of the overall biologics market. The historical insights are provided from 2016 to 2019 and projected trends are provided from 2020 to 2026. The quantitative data is provided in terms of value (USD Million) for 2016 – 2026. The qualitative data is reinforced by analyzing and providing numerous market dynamics (directly or indirectly affecting the industry) such as growth drivers, restraints, challenges, and opportunities.

We have included various industry analysis models in our report and extensively demonstrated the key business strategies and competitive landscape of the biologics market in our study. Our study also includes an analysis of Porter’s Five Forces framework for understanding the competitive strategies adopted by various stakeholders involved in the entire value chain of the Biologics market.

The report also offers an in-depth analysis of the market shares of each industry player and gives an outline of the market position of key players in the biologics market. Moreover, the study offers wide coverage of key strategic advances witnessed in the market such as new product launches, acquisitions & mergers, collaborations & joint ventures, funding & VC activities, agreements, partnerships, R&D activities, and regional expansion of key players of the biologics market.

The research study provides a critical assessment of the biologics industry by logically segmenting the market on the basis of type, source, disease category, manufacturing, and regions. Based on the past, present, and future trends, all the segments were analyzed from the bottom up, and the market sizes have been estimated from 2020 to 2026.

Technological advances increase in healthcare, reimbursement of biologics, ability to command high prices, growing mergers and acquisitions, rising biologics in the pipeline, etc. are few of the microeconomic factors affecting the positive growth of the biologics market within the forecast period. Moreover, some of the macroeconomic factors responsible for the growth of the global market include aging government initiatives, population, growing GDP across multiple emerging economies, etc.

However, factors hindering the global biologics market include manufacturing biologics from regulators, higher supervision during clinical trials, and pricing pressure. Furthermore, the rise of biosimilars is the major factor restraining the biologics market across the globe.

The biologics market is segmented based on type, source, disease category, and manufacturing. Based on type segmentation, the market is classified into monoclonal antibodies, vaccines, recombinant proteins, antisense, RNAi, & molecular therapy, and others. The global biologics market is segmented by source analysis into microbial, mammalian, and others. Based on the disease category, the biologics market is classified as oncology, infectious diseases, immunological disorders, cardiovascular disorders, hematological disorders, and others. In the end, the biologics market analysis is split into major manufacturing category including in-house and outsourced.

On the basis of geography, the global biologics market is divided into major five regions like Asia Pacific, Europe, North America, Latin America, and the Middle East, and Africa. Among the aforementioned regions, the Asia Pacific biologics market is anticipated to expand at a significant growth rate over the forecast period.

Key players operating in the biologics industry are F Hoffman La Roche, Samsung Biologics, Celltrion, Pfizer Inc., Amgen, Novo Nordisk A/S, Sanofi, Abbvie Inc., Merck & Co. Inc., Addgene, Johnson & Johnson Services Inc., Eli Lilly & Company, and others. The detailed description of players includes parameters such as financial overview, business strategy, key developments, and company overview of the company.

logoThis report segments the Global Biologics market as follows:

logo By Type Analysis

  • ·Monoclonal Antibodies
  • ·Vaccines
  • ·Recombinant Proteins
  • ·Antisense, RNAi, & Molecular Therapy
  • ·Others

logo By Source Analysis

  • ·Microbial
  • ·Mammalian
  • ·Others

logo By Disease Category Analysis

  • ·Oncology
  • ·Infectious Diseases
  • ·Immunological Disorders
  • ·Cardiovascular Disorders
  • ·Hematological Disorders
  • ·Others

logo By Manufacturing Analysis

  • ·In-house
  • ·Outsourced

logo By Region

logo·North America

  • a.U.S
  • b.Canada


  • a.Germany
  • b.France
  • c.U.K.
  • d.Italy
  • e.Spain
  • f.Rest of Europe

logo·Asia Pacific

  • a.China
  • b.Japan
  • c.India
  • d.South Korea
  • e.South-East Asia
  • f.Rest of Asia pacific

logo·Latin America

  • a.Brazil
  • b.Mexico
  • c.Rest of Latin America

logo·Middle East & Africa

  • a.GCC Countries
  • b.South Africa
  • c.Rest of Middle East & Africa


  • Statistical Analysis of the Past, Current, and Future Trends of the Industry with Validated Market Sizes Data

  • Direct and Indirect Rationales Impacting the Industry

  • In-depth and Micro Analysis of Viable Segments and Sub-segments

  • Companies and Vendors Market Share, Competitive Landscape, and Player Positioning Analysis

  • Demand Side (Consumption) and Supply Side (Production) Perspective and Analysis wherever applicable

  • Key Buyers and End-Users Analysis

  • Value Chain and Manufacturing Cost Structure Analysis wherever relevant

  • Key Marketing Strategies as well as Key Sales Channels adopted in the market

  • Investment Opportunity Analysis & Patents Analysis wherever feasible

  • Technological Road Map & Technical Analysis

  • Robust Research Methodology comprising dynamic mix (65%~35%) of Extensive Primary Research (primary interviews, ad-hoc surveys, questionnaires) and Protracted Secondary Research (proprietary in-house database, paid external databases, publically available validated sources)

logoKey Insights from Primary Research

  • According to interview with industry participants, the biologics market is anticipated to expand at a significant rate over the forecast period i.e. a compound annual growth rate of around 9.1% by 2026 end over 2019 in terms of market value
  • In terms of type segmentation, monoclonal antibodies segment has the dominant share in the global market
  • Among source segmentation, microbial segment stands at first position on the basis of market share
  • Eli Lilly & Company, Johnson & Johnson Services Inc., Addgene, Merck & Co. Inc., Abbvie Inc., Sanofi, Novo Nordisk A/S, Amgen, Pfizer Inc., Celltrion, Samsung Biologics, and F Hoffman La Roche are some of the prominent players of biologics market across the globe

logoKey Recommendations from Analysts

  • As per our analyst, top 10 manufacturers of the biologics market accounts for dominant revenue share in the global market
  • In-house manufacturing has dominant share in the global biologics market and will continue to do so over the forecast period
  • Biological drugs are highly dependent and sensitive on the conditions in which they are handled and manufactured is the main factor restraining the global market over the forecast period

In terms of sales value, the global biologics market is anticipated to grow at around 9% over the forecast period

Industry Major Market Players

  • F Hoffman La Roche
  •  Samsung Biologics
  •  Celltrion
  •  Pfizer Inc.
  •  Amgen
  •  Novo Nordisk A/S
  •  Sanofi
  •  Abbvie Inc.
  •  Merck & Co. Inc.
  •  Addgene
  •  Johnson & Johnson Services Inc.
  •  Eli Lilly & Company

Frequently Asked Questions

Strict enforcement of laws by government authorities mandating Biologics Market.
According to Facts and Factors research report, the global Biologics Market accrued earnings worth approximately XX (USD Billion) in 2020 and is predicted to gain revenue of about XX(USD Billion) by 2028, is set to record a CAGR of nearly XX% over the period from 2021 to 2028.
North America will contribute lucratively towards the global market value over the estimated timeline. The regional market surge is subject to large-scale presence of giant participants in countries such as the U.S. Apart from this, favorable compensation policies along with high acceptance of new Biologics Market will drive regional market trends. With regional governments enforcing strict laws pertaining to drug abuse, the market for Biologics Market in North America is set to witness exponential growth over years to come. Legalization of cannabis in countries such as Canada and U.S. through passing of acts in parliament is likely to enlarge scope of Biologics Market in North America over coming decade.
The key market participants include xx, xx, xx
why choose fnf
key questions answers